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Abstract
Background: Posterior tibialis tendon dysfunction (PTTD) is a common cause of foot pain and
dysfunction in adults. Clinical observations strongly suggest that the condition is progressive. There
are currently no controlled studies evaluating the effectiveness of exercise, orthoses, or orthoses
and exercise on Stage I or IIA PTTD. Our study will explore the effectiveness of an eccentric versus
concentric strengthening intervention to results obtained with the use of orthoses alone. Findings
from this study will guide the development of more efficacious PTTD intervention programs and
contribute to enhanced function and quality of life in persons with posterior tibialis tendon
dysfunction.
Methods/design: This paper presents the rationale and design for a randomized clinical trial
evaluating the effectiveness of a treatment regime for the non-operative management of Stage I or
IIA PTTD.
Discussion: We have presented the rationale and design for an RCT evaluating the effectiveness
of a treatment regimen for the non-operative management of Stage I or IIA PTTD. The results of
this trial will be presented as soon as they are available.
Background
Posterior tibialis tendon dysfunction (PTTD) is a com-
mon cause of foot pain and dysfunction in adults [1].
Clinical observations strongly suggest that the condition
is progressive. Descriptively, the varying presentations of
this condition are divided into four stages. Stage I is char-
acterized by mild swelling and medial ankle pain but no
deformity. Stage II is characterized by progressive flatten-
ing of the arch, with an abducted midfoot. In stage IIA, the
foot is still flexible; however, the tendon is functionally
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impaired. In Stage IIB, the tendon is incompetent, or even
ruptured. Stage III includes all of the signs of stage II; how-
ever, the hindfoot deformity becomes fixed. Myerson
added Stage IV for patients who progressed to valgus tilt
of the talus in the ankle mortise leading to lateral tibiota-
lar degeneration [2]. Despite its high prevalence [3], there
are no intervention guidelines for Stage I or II PTTD, and
surgical repair is the only definitive treatment for Stage III
or IV. Factors associated with PTTD include the following:
age-related degeneration, inflammatory arthritides [4,5],
hypertension, diabetes mellitus, obesity, and less fre-
quently acute traumatic rupture [2,5,6].
PTTD was previously thought to result from inflammatory
processes; however, surgical exploration and tissue analy-
sis has not confirmed the presence of inflammatory cells,
such as macrophages. The histopathological findings are
characterized by fibroblast hypercellularity, mucinous
degeneration, and neovascularization [7]. It is thought
that these changes result in disruption of the linear orien-
tation of the collagen bundles, representing tendon
degeneration and poor tissue response to healing [5].
Ultrasonography demonstrates increased tendon thicken-
ing, hypoechoic areas, irregular tendon structure with dis-
rupted fibers, and synovial sheath effusion within a
pathological posterior tibialis tendon [8,9]. The patholo-
gies described above are characteristic of tendinosis, not
tendinitis [7,10]. The consequences of the above findings
have significant ramifications in the management of per-
son's with PTTD. The emphasis of an intervention should
therefore be on promotion of tissue remodeling and
adaptation under optimal loading condition (rest,
orthoses, specific exercise), and time (at least three
months) [11]. This process requires effective patient edu-
cation in regards to length of time to resolution, activity,
consistent orthoses wear, exercise, and weight control
[11]. Additionally, it is important that the patient under-
stands that absence of pain does not reflect absence of
degeneration.
Frequently, progressive exercise programs serve as a cor-
nerstone for the non-surgical management of muscu-
loskeletal pathologies. Recent studies demonstrated
positive clinical results with eccentric calf muscle training
in individuals with painful chronic Achilles tendinosis
[12,13]. The participants were instructed in a concentric
or eccentric training regimen performed on a daily basis
for 12 weeks. Subjects in both groups were instructed to
perform the exercises even if tendon pain or discomfort
were experienced during exercise. Following completion
of the 12-week program, 82% of the participants assigned
to the eccentric group were satisfied with the results of the
intervention and had resumed their previous activity level
(before injury), compared to only 36% of those engaging
in concentric training (p < 0.002) [13].
The current study in persons with tibialis posterior tendi-
nopathy was motivated by the significant improvements
documented for the eccentric training program for per-
sons with Achilles tendinosis. The greater improvements
demonstrated in response to an eccentric compared to a
concentric strengthening program suggest that exercise
interventions which incorporate an eccentric strengthen-
ing component may lead to more successful outcomes
than concentric strengthening programs in the treatment
of tendinosis. Our study will explore the effectiveness of
an eccentric versus concentric strengthening intervention
while wearing an orthoses to results obtained while using
only an orthoses. There are no controlled studies evaluat-
ing the effectiveness of exercise, orthoses, or orthoses and
exercise on PTTD. Findings from this research will be
invaluable to PTTD intervention programs, as these data
will provide critical information that will lead to more
efficacious treatment interventions to enhance function
and quality of life in persons with posterior tibialis ten-
don dysfunction.
Methods
The University of Southern California Institutional
Review Board granted approval for this study.
Study population
Forty-five individuals with a current episode of medial
ankle or foot pain who present to the Department of
Orthopedics at the University of Southern California,
Long Beach Memorial, or one of 17 physical therapy clin-
ics participating in the Clinical Research Network of the
Department of Biokinesiology and Physical Therapy at the
University of Southern California will be recruited. All
subjects will be screened for eligibility according to the
inclusion and exclusion criteria by a research investigator.
Only subjects presenting with Stage I or IIA PTTD will be
enrolled in this study.
Inclusion criteria
To be eligible for participation, subjects must meet one of
the following criteria:
• pain at the medial ankle or foot reported for greater than
three months duration
￿ tenderness localized to the tibialis posterior tendon
Exclusion criteria
Participants will be excluded if they have one of the fol-
lowing conditions:
￿ fixed foot deformities
￿ previous foot surgeryBMC Musculoskeletal Disorders 2006, 7:49 http://www.biomedcentral.com/1471-2474/7/49
Page 3 of 7
(page number not for citation purposes)
￿ presence of any other concurrent foot pathology besides
posterior tibial tendon dysfunction
￿ inability to walk without assistive device
￿ nervous system problems (e.g., stroke, dementia, sei-
zures)
￿ cognitive dysfunction (e.g. TBI, CVA)
￿ uncontrolled cardiovascular disease
￿ evidence of cord compression
￿ uncontrolled hypertension
￿ infection
￿ severe respiratory disease
￿ pregnancy
￿ current or recent history of low back pain
￿ rheumatic joint disease
￿ peripheral vascular disease with sensory loss in the foot
￿ the subject identifies that she is pregnant
￿ any condition that the subject identifies which may limit
participation in physical activity
Outcome measures
The following outcome measures will be used in this ran-
domized clinical trial:
Foot Functional Index (FFI)
The FFI is a self-reported measure of pain, function, and
activity level associated with foot dysfunction consisting
of 23 items divided into 3 sub-scales. The scores range
from 0 to 10, with the higher scores indicating more disa-
bility. Both total and sub-scale scores are calculated [14].
The Foot Function Index (FFI) has been validated and
determined to be a reliable instrument for patients with
rheumatoid arthritis [14]. It is also recommended as a reli-
able measurement scale for use in other foot orthopedic
interventions trials [15] and has been shown to be a rea-
sonable tool for use with low functioning individuals
with foot disorders [16].
Global Rating Scale (GRS)
The GRS is a self-reported measure of overall change in
subject's condition resulting from a treatment interven-
tion with respect to activity limitations, symptoms, emo-
tions, and quality of life on a 15-point scale [17]. This
scale has been shown to demonstrate minimal differences
consistently across domains for both improvement and
deterioration [18].
Physical Activity Scale (PAS)
The PAS is a self-reported evaluation of time spent per-
forming daily activities such as sleep, rest, or physical
activity (work, leisure time, and exercise activity) on a 24-
hour scale. These data will be computed and represented
in metabolic equivalents (METs). The PAS has been
shown to be a valid self-reporting method for physical
activity. It also has high correlation with the physical-
activity diary, another self-reporting method of physical
activity [19].
Short Form 36 Health Survey (SF-36)
The SF-36 was developed as a multi-purpose measure of
health-related quality of life for use on general and spe-
cific populations without targeting a specific age, disease,
or treatment group [20]. The SF-36 has proven useful in
monitoring general and specific populations, comparing
the burden of different diseases, differentiating the health
benefits produced by different treatments, and in screen-
ing individual patient's health profile. The SF-36 was
developed for multiple applications and populations so
that the SF-36 scores from different samples could be
compared [20].
5-Minute walk test
The 5-minute walk test is a measure of function, endur-
ance, and gait velocity. We developed and field-tested spe-
cific verbal instructions to provide consistency in testing.
For the 5-Minute Walk Test the instructions read as fol-
lows: "This assessment involves walking as far as you com-
fortably can along this path for 5 minutes. Please let me
know when you're ready and I'll give you the signals,
"Ready" and "Go" to begin the timing. In order to keep
the conditions identical for all the subjects, I will not be
encouraging you during the walk, but I will let you know
when each full minute has passed. You may stop and rest
at any time during the assessment and continue walking
when you're able. I'll record the total distance you cover
over the 5-minute walk. Do you have any questions at this
time?"
50-Foot walk test
The Fifty-Foot Walk Test is a measure of gait velocity and
function. A specific verbal instruction, similar to that pre-
sented in the 5-Minute Walk Test was developed and field-
tested for this study.
Timed Up and Go (TUG)
The TUG is a test of basic functional mobility for elderly
persons. A specific verbal instruction, similar to that pre-BMC Musculoskeletal Disorders 2006, 7:49 http://www.biomedcentral.com/1471-2474/7/49
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sented in the 5-Minute Walk Test was developed and field-
tested for this study.
Visual Analogue Scale for pain (VAS)
The VAS is a single dimension scale with endpoints
marked as "no pain" and "worst pain possible." It is a reli-
able and valid measure of self-reported pain intensity
[21]. The stability of a VAS score has been reported (r =
0.9) [22]. The VAS will be used to measure pain intensity
after completion of the 5-Minute Walk Test, Fifty-Foot
Walk, and Timed Up and Go.
Evaluation
The research investigator performing both pre- and post-
intervention evaluations will be standardized to the
assessments and blinded to the subjects' group assign-
ment.
Timing of evaluation
Pre-intervention (PRE)
A standard orthopedic lower quadrant assessment docu-
menting structural condition, mobility and strength, will
be followed by the administration of the Foot Functional
Index, Physical Activity Scale, and SF-36 questionnaires, and
performance of a 5-Minute Walk Test, 50-Foot Walk Test, as
well as the Timed Up and Go. The Visual Analogue Scale for
pain will be administered after each functional test.
Post-intervention (POST)
At the conclusion of the intervention, subjects will be re-
evaluated following the same testing procedures and
using the same tests/questionnaires as during the initial
evaluation.
6-Month follow up (6-MONTH FOLLOW UP)
Six months after the completion of the intervention, sub-
jects will be asked to complete the Foot Functional Index,
the Physical Activity Scale, SF-36 questionnaire, and the Glo-
bal Rating Scale. A pre-addressed, stamped envelope will
be included in the correspondence. Patients will also be
contacted via phone to ensure a timely response.
Intervention
The following interventions will be provided in four clin-
ics located in the greater Los Angeles area:
Orthoses
At the time of initial evaluation, all subjects' feet will be
assessed and measured for orthoses. The orthoses will be
fabricated from a plaster mold obtained with the patient
lying prone and the foot in a subtalar joint neutral posi-
tion, using procedures described by Biomechanical Serv-
ice (1050 Central Ave. Suite D, Long Beach, CA 92832, 1-
800-942-2272). The same company will fabricate the
orthoses. The final design of the orthoses will be posted
according to the amount of rearfoot pronation when com-
paring relaxed subtalar joint neutral and relaxed standing,
(posting of 50–75% of the difference between these two
positions). Additional, in the presence of a bony forefoot
deformity, the forefoot will also be posted at 50% of the
deformity. The subjects will be asked to comply with the
protocol by wearing the orthoses 90% of their waking
hours in athletic shoes.
Stretching
All participants will perform calf stretches (Figure 1). Each
subject will be issued a "Slant by OPTP" (OPTP, PO Box
Minneapolis, MN 55447-0009) to be used for calf stretch-
ing. The slant is a lightweight, portable foam wedge. The
subjects will be instructed to place the slant facing away
from a wall, within a foot length distance. They will then
place the shod foot of the "to be stretched leg" on the slant
with the toes pointing up. The subject will be instructed to
lean forward until he/she perceives a strong but tolerable
stretch in the calf muscles. This maneuver will be repeated
3 times with the knee extended to target the gastrocne-
mius muscle and 3 times with the knee slightly flexed to
more selectively isolate the soleus muscle. This position
will be held for 30 seconds. The lumbar spine will be
placed in a "neutral" position to reduce the potential risk
of strain to the low back region. Additional fine points of
the technique, specific to the needs of individual subjects,
will be taught to the patient by the intervention therapist.
The subjects will receive a pictorial and written descrip-
tion of the stretching technique.
Progressive resistive exercise
Previous work has indicated that the tibialis posterior is
preferentially recruited during a resisted foot adduction
exercise in persons with pes planus [23] and that this mus-
cle is selectively activated when flat-footed subjects per-
form the exercise while wearing arch supporting orthoses
and shoes [24]. Therefore, the exercises will consist of iso-
lated loading (plantar flexion and adduction) of the pos-
terior tibialis musculotendinous unit and will be
performed with the subjects wearing both orthoses and
shoes. The exercises will be performed using a specialized
exercise unit, which can be manipulated to progressively
load the tendon either concentrically or eccentrically
depending on group assignment (Figure 2). Subjects will
begin resistive exercise when custom orthoses are deliv-
ered (1–2 weeks after evaluation).
Intervention group assignment
Subjects will be randomly assigned to one of the three
groups: 1) orthoses wear and calf stretching; 2) orthoses
wear, calf stretching, and a progressively challenging con-
centric exercise program; 3) orthoses wear, calf stretching,
and a progressively challenging eccentric exercise pro-
gram.BMC Musculoskeletal Disorders 2006, 7:49 http://www.biomedcentral.com/1471-2474/7/49
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Orthoses (ORTH)
Subjects in the orthoses group will wear custom foot
orthoses in athletic shoes for 90% of waking hours. They
will be instructed in performing calf stretches as described
earlier. A series of six, 30-second stretches on the involved
Exercise unit for isolated tibialis posterior exercise Figure 2
Exercise unit for isolated tibialis posterior exercise. (1) LED displaying static plantar flexion from pressure sensors under fore-
foot; (2) Constant force extension spring for dynamic adduction; (3) Lever to allow passive adduction or abduction of the foot.
A) Standing gastrocnemius stretch Figure 1
A) Standing gastrocnemius stretch. B) Standing soleus stretch.BMC Musculoskeletal Disorders 2006, 7:49 http://www.biomedcentral.com/1471-2474/7/49
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leg will be performed twice daily. Subjects will begin to
perform calf stretches on the day of initial evaluation.
Orthoses + concentric exercise program (CONC)
Subjects in the concentric exercise group will wear custom
foot orthoses and perform calf stretches as described for
the orthoses group. They will also be instructed in the per-
formance of the concentric exercise program (consisting
of plantar flexion and adduction using a specialized exer-
cise unit). The exercise will be performed slowly (5 sec-
onds thought the range of motion). A series of 3 sets of 15
repetitions will be performed twice daily on the involved
side. Between sets, rest periods will be 1–2 minutes. The
resistance, provided by a constant force extension spring,
will be set at 2 pounds for the first week and progressed to
tolerance and ability throughout the 10-week concentric
intervention program.
Orthoses + eccentric exercise program (ECC)
Subjects in the eccentric exercise group will wear custom
foot orthoses and perform calf stretches as described for
the orthoses group. They will also be instructed in the per-
formance the eccentric exercise regimen using a special-
ized exercise unit, which requires plantar flexion and
resistance to adduction. The exercise will be performed
slowly (5 seconds throughout the range of motion). A
series of 3 sets of 15 repetitions will be performed twice
daily on the involved side. Between sets, rest periods will
be 1–2 minutes. The resistance, provided by a constant
force extension spring, will be set at 2 pounds for the first
week and progressed to tolerance and ability throughout
the 10-week eccentric intervention program.
Subjects will have an Exercise Record Chart where they
will record the number of performed stretches and exer-
cises as well as reflections on their performance (ease; if
discomfort, then location and intensity). Subjects will
meet with an intervention therapist once per week for 10
weeks so that the quality of stretches and motion during
the exercise can be assessed and resistance can be added as
tolerated or decreased as needed.
Data analysis
A 3 × 3 ANOVA with repeated measures will identify dif-
ferences in the FFI across groups (ORTH, CONC, ECC)
and between testing sessions (PRE, POST, 6-MONTH
FOLLOW UP). All analyses will be performed using SPSS
statistical software (SPSS Inc., Chicago, IL). All signifi-
cance levels will be set at p < 0.05.
Sample size
The selection of 45 subjects for this study (15 subjects per
group), is based on clinical observations, attrition rate,
and power analysis. Clinical observations have indicated
that the inter-subject variability with respect to pain, disa-
bility and function is moderate to high. Therefore, all
power calculations have taken this increased variability
into consideration. A 20% subject attrition rate is antici-
pated. The possible attrition rate is attributed to length of
the rehabilitative program, elimination of symptoms, or
increase of symptoms, need for surgery, and prior attrition
rate of existing randomized control trials. The Foot Func-
tional Index will be used as the primary outcome of this
study. The remaining functional, health status, and pain
variables will be used as secondary outcome variables.
Power calculations were based on an alpha level of 0.05
and beta of 0.8 with respect to the FFI pain score.
Discussion
We have presented the rationale and design for an RCT
evaluating the effectiveness of a treatment regimen for the
non-operative management of Stage I or IIA PTTD. The
results of this trial will be presented as soon as they are
available.
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